The Latest Breaking News from SYK

Healthcare behemoths, including the biggest name of them all, are increasing their dividends. Additionally, AMGN's dividend yield now sits solidly above 3%.

Healthcare giant Stryker has notably underperformed the broader market over the past year, yet analysts remain optimistic about the stock’s prospects.

Stryker has underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Though Stryker has underperformed the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Although Stryker has slightly underperformed the Nasdaq over the past year, its fundamentals have remained strong, and analysts remain strongly bullish on the stock’s prospects.

Stryker Corporation is all geared to report its first-quarter results later this month, and analysts project its earnings to increase by a single digit.

Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.

Stryker has outperformed the S&P 500 recently, and analysts remain highly optimistic about the stock’s prospects.

Powered by rapid AI advancements, enhanced automation processes, and growing demand for commercial adoption, modern robotics is reshaping the automation landscape. Investors looking to capitalize on this momentum might find opportunities in Stryker (SYK), Fanuc Corporation (FANUY), and UiPath (PATH). Continue to read….